<DOC>
	<DOCNO>NCT01446679</DOCNO>
	<brief_summary>This study evaluate control effect atrovastatin plasma lipid achieve category-specific target lipid level .</brief_summary>
	<brief_title>Special Drug Use-Results Survey Lipitor Tablets</brief_title>
	<detailed_description>To confirm low-density lipoprotein cholesterol ( LDL-C ) -lowering effect 24 week treatment LipitorÂ® ( Generic Name : atorvastatin calcium ) Tablets determine rate achievement category-specific target LDL-C level patient hypercholesterolemia ; confirm usefulness ( efficacy safety ) atorvastatin patient respond sufficiently statin therapy</detailed_description>
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<criteria>Patients hypercholesterolemia achieve categoryspecific target lipid level</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>Lipitor</keyword>
	<keyword>HMG-CoA reductase inhibitor</keyword>
</DOC>